Anti-Signal Peptide Peptidase Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the aminoterminal region of Signal Peptide Peptidase (HM13), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential
UniProt
Q8TCT9
Size
100ug
Cat. #
RP3Signal Peptide Peptidase

In stock

SKU
RP-Signal Peptide Peptidase

Options

As low as: $130.00

Target Overview

Signal peptide peptidase (SPP, gene symbol HM13, UniProt Q8TCT9, EC 3.4.23.-) is an intramembrane aspartyl protease localized to the endoplasmic reticulum membrane. As a 377-amino acid polytopic membrane protein, SPP catalyzes the regulated intramembrane proteolysis of signal peptides after their cleavage from nascent precursor proteins during translocation into the ER. This liberates signal peptide fragments from the membrane into the cytoplasm, where they can serve as substrates for antigen presentation or be degraded. SPP is required for generating HLA-E epitopes from MHC class I signal peptides, establishing its role in adaptive immunity and minor histocompatibility antigen responses. The enzyme also cleaves other type II membrane protein substrates, including presenilin-1 (PSEN1) and XBP1 isoform 1, the latter in a DERL1/RNF139-dependent manner. SPP belongs to a small family of presenilin-like intramembrane proteases and shares structural homology with γ-secretase components. Researchers study SPP in contexts ranging from ER-associated degradation and proteostasis to viral replication and lipid metabolism.

Background

SPP executes intramembrane cleavage within the hydrophobic environment of the ER bilayer, a process distinct from canonical soluble proteases. Following cotranslational removal of signal sequences by signal peptidase, SPP liberates these hydrophobic remnants embedded in the ER membrane, preventing their accumulation and potential toxicity. Substrates include not only signal peptides from diverse secretory pathway proteins but also type II membrane proteins such as PSEN1 and the unfolded protein response mediator XBP1. The role of SPP in antigen presentation has been well documented: peptides derived from SPP cleavage are processed by the proteasome and presented on HLA-E, making SPP essential for immune surveillance and contributing to minor histocompatibility antigen H13-mediated graft rejection. Recent work has expanded the pathophysiological relevance of SPP beyond immunity. Cao et al (2025) demonstrated that macrophage HM13 enhances foamy macrophage formation and atherosclerosis, implicating SPP in lipid metabolism and cardiovascular disease. Qiao et al (2025) identified SPP as a druggable host dependency factor for multiple flaviviruses, suggesting antiviral therapeutic opportunities. Jin et al (2025) reported HM13 expression correlates with PI3K/Akt and p53 pathway activity in colorectal cancer, adding oncology to the list of disease contexts. SPP has also been implicated in hepatitis C virus polyprotein maturation, where it may cleave residual signal peptide from the viral core protein. Triple Point Biologics offers three rabbit polyclonal antibodies raised against the aminoterminal region of Signal Peptide Peptidase, validated for Western blot. These reagents support investigations of SPP expression, localization, and function across cell biology, immunology, virology, and disease models.

References

  1. Cao Y et al (2025) Macrophage HM13/SPP Enhances Foamy Macrophage Formation and Atherogenesis. Adv Sci (Weinh). PubMed · 10.1002/advs.202412498
  2. Qiao W et al (2025) Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses. Proc Natl Acad Sci U S A. PubMed · 10.1073/pnas.2421573122
  3. Jin X et al (2025) The role of HM13 expression and its relationship to PI3K/Akt and p53 signaling pathways in colorectal cancer. Tissue Cell. PubMed · 10.1016/j.tice.2024.102702

Additional Specifications

Gene Symbol HM13
UniProt ID Q8TCT9
Host Species Rabbit
Species Reactivity Validated- Human
Potential
Pack Size 100ug
Immunogen (Aminoterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-50.
Immunogen (Second Cytoplasmic Loop)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 122-157.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 327-377.
Alternate Names SPP, HM13, Minor histocompatibility antigen H13, Intramembrane protease 1, IMP-1, IMPAS-1, hIMP1, Presenilin-like protein 3, Signal peptide peptidase-like 1, EC 3.4.23.-

Frequently Asked Questions

What molecular weight band should I expect for Signal Peptide Peptidase on Western blot?

Signal peptide peptidase (SPP, HM13) migrates at approximately 42 kDa on SDS-PAGE under reducing conditions, corresponding to its 377-amino acid sequence. The protein is a polytopic membrane protein with multiple transmembrane domains, so complete denaturation with adequate detergent is important for consistent migration. Some labs report a minor higher-molecular-weight species around 50 kDa, potentially reflecting post-translational modifications or incomplete denaturation. Always include a positive control such as HeLa or HEK293 lysate, where SPP is endogenously expressed at moderate levels in the ER fraction.

What is the recommended starting dilution for this SPP antibody in Western blot?

We recommend starting at 1:1000 dilution in blocking buffer (5 percent non-fat milk or BSA in TBST) for overnight incubation at 4°C. This polyclonal rabbit antibody has been validated at this dilution in human lysates. Depending on your sample type and SPP expression level, you may optimize between 1:500 and 1:2000. Membrane proteins like SPP often require stronger extraction conditions—consider RIPA buffer supplemented with 1 percent SDS or urea-based lysis for optimal solubilization from ER membranes. Titre the antibody with your specific lysate preparation to establish your working dilution.

Does Signal Peptide Peptidase have isoforms or splice variants I should know about?

The HM13 gene encoding SPP produces a single major isoform of 377 amino acids. There are four additional human SPP-like proteins (SPPL2a, SPPL2b, SPPL2c, SPPL3) that share sequence homology and intramembrane protease activity but are distinct gene products with different tissue distribution and substrate specificity. This antibody is raised against SPP (HM13) and has not been validated for cross-reactivity with SPP-like family members. If you are studying the broader SPP family, confirm specificity by siRNA knockdown or verify the expected subcellular localization, as SPP is ER-resident while SPPL proteins differ.

Will this antibody recognize mouse or rat Signal Peptide Peptidase?

This antibody is validated for human SPP. Mouse and rat SPP (HM13 orthologs) share approximately 85 percent amino acid identity with human SPP, so cross-reactivity is possible but not validated by us. If you plan to use mouse or rat samples, we recommend empirical testing at the standard 1:1000 dilution with appropriate positive controls such as mouse liver or brain lysate, where SPP is expressed. Consider running a parallel human lysate to compare signal intensity and specificity. Predicted cross-reactivity based on sequence homology does not guarantee antibody performance; always validate in your species of interest.

What positive control lysate should I use for Signal Peptide Peptidase Western blots?

HeLa, HEK293, or Jurkat whole-cell lysates are reliable positive controls, as SPP is constitutively expressed in most human cell lines due to its housekeeping role in ER-associated signal peptide cleavage. For enriched signal, prepare microsomal or ER membrane fractions, since SPP is an ER-resident intramembrane protease. Human liver or placenta tissue lysates also express SPP at detectable levels. Avoid using cytosolic fractions as negative controls unless you have confirmed clean fractionation; residual membrane contamination will produce false positives. A blocking peptide or siRNA knockdown lysate serves as a specificity control.

How should I store this Signal Peptide Peptidase antibody and what is the shelf life?

Store the antibody at –20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation. The 100 µg stock supplied in glycerol-containing buffer is stable for at least 12 months at –20°C. For convenience, you may prepare working dilutions in blocking buffer with 0.02 percent sodium azide and store at 4°C for up to two weeks. Do not store diluted antibody long-term. After thawing an aliquot, keep on ice during use and return promptly to –20°C. If you observe increased background or loss of signal, prepare a fresh aliquot.

Can I use this SPP antibody for immunofluorescence or immunohistochemistry?

Triple Point Biologics antibodies are validated for Western blot as standard practice. For immunofluorescence of SPP, choose a permeabilization method compatible with ER membrane proteins—0.1 percent Triton X-100 or digitonin works well. SPP localizes to the ER, so expect a reticular perimuclear staining pattern. Start at 1:100 to 1:200 dilution for IF. For IHC on paraffin sections, antigen retrieval (citrate buffer, pH 6.0, heat-induced) is typically required for membrane proteases. We have not formally validated dilutions for IF or IHC on this specific clone; empirical optimization is necessary.

What lysis buffer is best for extracting Signal Peptide Peptidase from cells?

Because SPP is a polytopic ER membrane protein with multiple transmembrane helices, standard non-denaturing buffers may incompletely solubilize it. RIPA buffer (150 mM NaCl, 1 percent NP-40, 0.5 percent deoxycholate, 0.1 percent SDS, 50 mM Tris pH 8.0) supplemented with protease inhibitors is a good starting point. For stubborn membrane proteins, increase SDS to 1 percent or add 6–8 M urea. Sonication or multiple freeze-thaw cycles can improve yield. Avoid mild non-ionic detergents alone, as they leave SPP partially membrane-associated, leading to weak or smeared Western blot signal.

Validation imagery coming soon

Western blot validation figures for RP-Signal Peptide Peptidase will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • SPP
  • HM13
  • Minor histocompatibility antigen H13
  • Intramembrane protease 1
  • IMP-1
  • IMPAS-1
  • hIMP1
  • Presenilin-like protein 3
  • Signal peptide peptidase-like 1
  • EC 3.4.23.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →